Oral single- and repeated-dose toxicity studies on Geranti Bio-Ge Yeast®, organic germanium fortified yeasts, in dogs

Journal of Toxicological Sciences

Volumn 29, Issue 5, 2004, Pages 555-569

  Lee, Jong Sung ^a   Park, Jong Il ^a   Kim, Sun Hee ^a   Lee, Hye Young ^a   Hwang, Zai Zhi ^a   Park, Cheol Beom ^a   Sohn, Tsang Uk ^b   Shin, Sunhee ^c   Kang, Jong Koo ^c   Kim, Yun Bae ^c  

^a Biotoxtech Co Ltd   (South Korea)

^b GerantiPharm Co   (South Korea)

^c Chungbuk National University   (South Korea)

Author keywords

Dogs; Geranti Bio Ge Yeast ; Oral; Organic germanium fortified yeasts; Single and repeated dose toxicities

Indexed keywords

ALBUMIN; GERANTI BIO GE YEAST; GERMANIUM DERIVATIVE; GLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CONTROLLED STUDY; DOG; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ELECTROCARDIOGRAM; FEMALE; GENDER; HEART RATE; HEMATOLOGY; LIVER; LONG TERM CARE; MALE; NONHUMAN; OPHTHALMOSCOPY; PARTIAL THROMBOPLASTIN TIME; QT INTERVAL; RETICULOCYTE; RR INTERVAL; TOXICITY TESTING; URINALYSIS; WEIGHT GAIN; YEAST;

ANIMALIA; CANIS FAMILIARIS;

EID: 19944432035     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.29.555     Document Type: Article

References (48)

1. Ahn, D.-C., Choi, Y.-S., Park, D.-H., Park, S.-Y., Han, Z.-Z., Song, I.-S., Kim, E.-J., Lee, M.-S. and Kwon, M.-S. (2001a): Chronic toxicity of Dry Yeast-G (biogermanium) orally administered to rats for 10 consecutive months. Korean J. Lab. Ani. Sci., 17, 109-118.
2. Ahn, D.-C., Choi, Y.-S., Park, D.-H., Park, S.-Y., Han, Z.-Z., Song, I.-S., Kim, E.-J., Lee, M.-S. and Kwon, M.-S. (2001b): Chronic toxicity of Dry Yeast-G (biogermanium) orally administered to beagle dogs for 10 consecutive months. Korean J. Lab. Ani. Sci., 17, 99-108.
3. n in rats. Appl. Organometallic Chem., 6, 267-272.
4. Asai, K. (1980): Miracle Cure: Organic Germanium. Japan Publications Inc., Tokyo.
5. Asai, K. (1984): Ge-132. In Outline, pp. 1-64, Asai Germanium Research Institute, Tokyo.
6. Aso, H., Suzuki, F., Ebina, T. and Ishida, N. (1989): Antiviral activity of carboxyethylgermanium sesquioxide (Ge-132) in mice infected with influenza virus. J. Biol. Resp. Mod., 8, 180-189.
7. Aso, H., Suzuki, F., Yamaguchi, T., Hayashi, Y., Ebina, T. and Ashida, N. (1985): Induction of Interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol. Immunol., 29, 65-74.
8. Boder, E.T. and Wittrup, K.D. (2000): Yeasty surface display for directed evolution of protein expression, affinity, and stability. Methods Enzymol., 328, 430-444.
9. Brutkiewicz, R.R. and Suzuki, F. (1987): Biological activities and antitumor mechanism of an immunopotentiating organogermanium compound, Ge-132 (Review). In Vivo, 1, 189-203.
10. Gerber, G.B. and Leonard, A. (1997): Mutagenicity, carcinogenicity and teratogenicity of germanium compounds. Mutat. Res., 387, 141-146.
11. Goodman, S. (1988): Therapeutic effects of organic germanium. Med. Hypotheses, 26, 207-215.
12. Hammett, F.S., Nowrey, J.E. Jr. and Muller, J.H. (1992): The erythropoietic action of germanium dioxide. J. Exp. Med., 35, 173-180.
13. Han, C., Yin, W.G. and Shen, M. (1992): Inhibition by germanium oxide of the mutagenicity of cadmium chloride in various genotoxicity assays. Food Chem. Toxicol., 30, 521-524.
14. Hess, B., Raisin, J., Zimmermann, A., Horber, F., Bajo, S., Wyttenbach, A. and Jaeger, P. (1993): Tubulointerstitial nephropathy persisting 20 months after discontinuation of chronic intake of germanium lactate citrate. Am. J. Kid. Dis., 21, 548-552.
15. Ikemoto, K., Kobayashi, M., Fukumoto, T., Morimatsu, M., Pollard, R.B. and Suzuki, F. (1996): 2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells. Experimentia, 52, 159-166.
16. Jao, S.-W., Lee, W. and Ho, Y.-S. (1990): Effect of germanium on 1,2-dimethylhydrazine-induced intestinal cancer in rats. Dis. Colon Rectum, 33, 99-104.
17. Kaars Sijpesteijn, A., Rukens, F. and van der Kerk, G.J.M. (1964): Antimicrobial activity of organogermanium derivatives. Nature, 201, 736.
18. Kada, T., Mochizuki, H. and Miyao, K. (1984): Antimutagenic effects of germanium oxide on Trp-P-2 induced frameshift mutations in Salmonella typhimurium TA98 and TA1538. Mutat. Res., 125, 145-151.
19. Kanda, K., Ikawa, E. and Tagawa, Y. (1990): Subacute toxicity test of proxigermanium (SK-818) in rats. Clin. Rep., 24, 46-89.
20. Kang, K.-S., Yun, J.-W., Yoon, B.S., Lim, Y.-K. and Lee, Y-S. (2001): Preventive effect of germanium dioxide on the inhibition of gap junctional intercellular communication by TPA. Cancer Lett., 166, 147-153.
21. Klapcinska, B. and Chmielowski, J. (1986): Binding of germanium to Pseudomonas putida cells. Appl. Environ. Microbiol., 51, 1144-1147.
22. Korea Food and Drug Administration (1999): Guidelines for Toxicity Tests of Drugs and Related Materials, Documentation #1999-61, Korea Food and Drug Administration, Seoul.
23. Krapf, R., Schaffner, T. and Iten, P.X. (1992): Abuse of germanium associated with fatal lactic acidosis. Nephron, 62, 351-356.
24. Kushinirov, V.V. (2000): Rapid and reliable protein extraction from yeast. Yeast, 16, 857-860.
25. Lee, C.-H., Lin, R.-H., Liu, S.-H. and Lin-Shiau, S.-Y. (1998): Effects of germanium oxide and other chemical compounds on phenylmercury acetate-induced genotoxicity in cultured human lymphocytes. Environ. Mol. Mutagen., 31, 157-162.
26. Matsumuro, K., Izumo, S., Higuchi, I., Ronquillo, A.T., Takahashi, K. and Osame, M. (1993): Experimental germanium dioxide-induced neuropathy in rats. Acta Neuropathol. (Berl.), 86, 547-553.
27. Min, S.-J., Zheng, M.-S., Park, J.-L, Lee, J.-S., Kim, Y.-B., Kang, J.-K., Shon, T.-U. and Park, C.-B. (2004): Genotoxicity studies on Geranti Bio-Ge Yeast®, an organic germanium synthesized in yeasts. Korean J. Lab. Ani. Sci., 20, 81-88.
28. Montgomery, D.C. (1984): Design and Analysis of Experiments, John Wiley & Sons.
29. Nakada, Y., Kosaka, T., Kuwabara, M., Tanaka, S., Sato, K. and Koide, F. (1993): Effects of 2-carboxyethylgermanium sesquioxide (Ge-132) as an immunological modifier of postsurgical immunosuppression in dogs. J. Vet. Med. Sci., 55, 795-799.
30. Nakagawa, H., Segawa, M. and Kanore, M. (1990): Chronic toxicity test of proxigermanium (SK-818) in rats. Clin. Rep., 24, 144-177.
31. Nobohiro, W., Osamu, I., Takuro, K. and Koichi, Y. (1980): New approaches to using spent brewer's yeast. ASBC J., 38, 5-8.
32. Olsen, B., McDonald, J. Jr., Noblitt, T., Li, Y. and Ley, M. (1995): Modifying role of trace elements on the mutagenicity of benzo(a)pyrene. Mutat. Res., 335, 21-26.
33. Raisin, J., Hess, B., Blatter, M., Zimmermann, A., Descoeudres, C., Horber, F.F. and Jaeger, P. (1992): Toxicity of an organic germanium compound: Deleterious consequences of a "natural remedy". Schweiz Med. Wochenschr., 122, 11-13.
34. Rosenfeld, G. and Wallace, E.J. (1953): Studies of the acute and chronic toxicity of germanium. Am. Med. Assoc. Arch. Ind. Hyg. Occup. Med., 8, 466-479.
35. Sanai, T., Okuda, S., Onoyama, K., Oochi, N., Takaichi, S., Mizuhira, V. and Fujishima, M. (1991a): Chronic tubulointerstitial changes induced by germanium dioxide in comparison with carboxyethylgermanium sesquioxide. Kidney Int., 40, 882-890.
36. Sanai, T., Onoyama, K., Osato, S., Motomura, K., Oochi, N., Oh, Y., Okuda, S., Takaichi, S. and Fujishima, M. (1991b): Dose dependency of germanium dioxide-induced nephrotoxicity in rats. Nephron, 57, 349-354.
37. Schauss, A.G. (1991): Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide. Biol. Trace Elem. Res., 29, 267-280.
38. Slawson, R.M., van Dyke, M.I., Lee, H. and Travors, J.T. (1992): Germanium and silver resistance, accumulation, and toxicity in microorganisms. Plasmid, 27, 72-79.
39. Suzuki, F., Brutkiewicz, R.R. and Pollard, R.B. (1985): Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours. Br. J. Cancer, 52, 757-763.
40. Suzuki, Y. and Taguchi, K. (1983): Pharmacological studies of carboxyethylgermanium sesquioxide (Ge-132). Pharmacometrics, 26, 803-810.
41. Tao, S.-H. and Bolger, P.M. (1997): Hazard assessment of germanium supplements. Regul. Toxicol. Pharmacol., 25, 211-219.
42. Taylor, A. (1991): Effects of germanium health supplements in the rat. Clin. Chem., 37, 985.
43. Van der Spoel, J.I., Stricker, B.H.C., Esseveld, M.R. and Schipper, M.E.I. (1990): Dangers of dietary germanium supplements. Lancet, 336, 117.
44. Vandyke, M.I., Lee, H. and Travors, J.T. (1989): Germanium toxicity in selected bacterial and yeast strains. J. Ind. Microbiol., 4, 299-306.
45. Vouk, V. (1986): Germanium. In Handbook on the Toxicology of Metals (Friberg, L. et al., eds.), pp. 255-266, Elsevier.
46. Wei, X.S. (1992): Effect of yeast on bioenrichment of germanium. Food Sci., 149, 49-54.
47. Yim, S.Y., Lee, I.Y. and Kim, T.S. (1999): Enzyme histochemical study of germanium dioxide-induced mitochondrial myopathy in rats. Yonsei Med. J., 40, 69-75.
48. Young, M.R. and Tyk, B.K. (1997): Mcm2 and Mcm3 are constitutive nuclear proteins that exhibit distinct isoforms and bind chromatin during specific cell cycle stages of Saccharomyces cerevisiae. Mol. Biol. Cells, 8, 1587-1601.